摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

n-butyl 3-formylcinnamate | 1063628-07-8

中文名称
——
中文别名
——
英文名称
n-butyl 3-formylcinnamate
英文别名
butyl (E)-3-(3-formylphenyl)prop-2-enoate
n-butyl 3-formylcinnamate化学式
CAS
1063628-07-8
化学式
C14H16O3
mdl
——
分子量
232.279
InChiKey
SFJPGMOGKIATEP-BQYQJAHWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    17
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3'-氟苯乙酮n-butyl 3-formylcinnamate氢氧化钾盐酸 作用下, 以 乙醇 为溶剂, 反应 24.0h, 以72%的产率得到3-[3-[3-(3-fluorophenyl)-3-oxopropen-1-yl]benzene]propenoic acid
    参考文献:
    名称:
    [EN] NEW HISTONE DEACETYLASES INHIBITORS
    [FR] NOUVEAUX INHIBITEURS DES HISTONE-DEACETYLASES
    摘要:
    新的组织脱乙酰化酶抑制剂具有抗肿瘤活性,以及其制备方法在此进行描述。这些化合物属于结构式(I),其中R1是含有至少两个共轭双键的直链或支链,A是可选择地取代的苯或吡啶环,Ar是芳基或杂芳基团,R3是氢或烷氧基烷基。该申请还描述了这些化合物在治疗与组织脱乙酰化酶活性失调相关的疾病,如肿瘤中的应用,以及用于给需要该治疗的患者的相关药物组合物。
    公开号:
    WO2006037761A1
  • 作为产物:
    描述:
    丙烯酸丁酯3-碘苯甲醛 在 palladium diacetate potassium phosphate 作用下, 以 N,N-二甲基乙酰胺 为溶剂, 反应 24.0h, 以47%的产率得到n-butyl 3-formylcinnamate
    参考文献:
    名称:
    [EN] NEW HISTONE DEACETYLASES INHIBITORS
    [FR] NOUVEAUX INHIBITEURS DES HISTONE-DEACETYLASES
    摘要:
    新的组织脱乙酰化酶抑制剂具有抗肿瘤活性,以及其制备方法在此进行描述。这些化合物属于结构式(I),其中R1是含有至少两个共轭双键的直链或支链,A是可选择地取代的苯或吡啶环,Ar是芳基或杂芳基团,R3是氢或烷氧基烷基。该申请还描述了这些化合物在治疗与组织脱乙酰化酶活性失调相关的疾病,如肿瘤中的应用,以及用于给需要该治疗的患者的相关药物组合物。
    公开号:
    WO2006037761A1
点击查看最新优质反应信息

文献信息

  • Palladium Nanoparticles on Graphite Oxide as Catalyst for SuzukiMiyaura, MizorokiHeck, and Sonogashira Reactions
    作者:Luigi Rumi、Gil M. Scheuermann、Rolf Mülhaupt、Willi Bannwarth
    DOI:10.1002/hlca.201000412
    日期:2011.6
    system was applied successfully to SuzukiMiyaura couplings of some aryl chlorides and to the MizorokiHeck as well as the Sonogashira reaction showing relatively high activities and good selectivities. Like with other ligand‐free supported systems, the reaction proceeded dominantly by a homogeneous mechanism, but attack of an aryl iodide to Pd‐nanoparticles can be excluded as substantial contribution
    Pd 2+交换的氧化石墨(GO)用作Pd纳米颗粒形成的预催化剂,然后沉积在高度官能化的碳质载体上。这种多功能的,空气稳定的,和游离配位体系统成功地应用于铃木宫浦一些芳基的偶合和所述Mizoroki 赫克以及所述的Sonogashira反应显示出较高的活性和良好的选择性。与其他无配体支持的体系一样,该反应主要通过均相机理进行,但是可以排除芳基纳米颗粒的攻击,因为它对整个催化过程的重要贡献。该系统除了直接制备和在空气中稳定外,还结合了均相和异相催化的优点。
  • Histone Deacetylases Inhibitors
    申请人:Minucci Saverio
    公开号:US20080096889A1
    公开(公告)日:2008-04-24
    New inhibitors of histone deacetylases having antitumor activity, and the process of preparation thereof are herein described. These compounds belong to the structural formula (I) where R 1 is a linear or branched chain containing at least two conjugated double bonds, A is an optionally substituted phenyl or pyridyl ring, Ar is an aryl or heteroaryl group, and R 3 is hydrogen or alkoxyalkyl. The application also describes the use of said compounds in the treatment of diseases associated to the deregulation of histone deacetylases activity, such as tumors, as well as the relevant pharmaceutical compositions for administration to patients requiring said treatment.
    本文描述了具有抗肿瘤活性的组蛋白去乙酰化酶抑制剂及其制备过程。这些化合物属于结构式(I),其中R1是一个含有至少两个共轭双键的线性或支链,A是一个可选取代的苯基或吡啶基环,Ar是芳基或杂环基团,而R3是氢或烷氧基烷基。该申请还描述了这些化合物在治疗与组蛋白去乙酰化酶活性失调相关的疾病,如肿瘤方面的应用,以及用于给需要该治疗的患者的相关药物组成部分。
  • NEW HISTONE DEACETYLASES INHIBITORS
    申请人:MINUCCI Saverio
    公开号:US20100240660A1
    公开(公告)日:2010-09-23
    New inhibitors of histone deacetylases having antitumor activity, and the process of preparation thereof are herein described. These compounds belong to the structural formula (I) where R 1 is a linear or branched chain containing at least two conjugated double bonds, A is an optionally substituted phenyl or pyridyl ring, Ar is an aryl or heteroaryl group, and R 3 is hydrogen or alkoxyalkyl. The application also describes the use of said compounds in the treatment of diseases associated to the deregulation of histone deacetylases activity, such as tumors, as well as the relevant pharmaceutical compositions for administration to patients requiring said treatment.
    本文描述了具有抗肿瘤活性的新型组蛋白去乙酰化酶抑制剂及其制备方法。这些化合物属于结构式(I),其中R1是含有至少两个共轭双键的线性或支链,A是可选取代的苯基或吡啶基环,Ar是芳基或杂环芳基基团,R3是氢或烷氧基烷基。该申请还描述了在治疗与组蛋白去乙酰化酶活性失调相关的疾病,如肿瘤方面使用这些化合物的方法,以及适用于需要该治疗的患者的相关药物组合物。
  • Triaryl phosphine-functionalized N-heterocyclic carbene ligands for Heck reaction
    作者:Ai-E Wang、Jian-Hua Xie、Li-Xin Wang、Qi-Lin Zhou
    DOI:10.1016/j.tet.2004.10.049
    日期:2005.1
    A new type of triaryl phosphine-functionalized imidazolium salts 6 were prepared. Their palladium complexes, generated in situ, were successfully applied in the palladium-catalyzed Heck reaction. Using 1 mol% of Pd(dba)(2) and 10 mol% 6c in the presence of 2 equiv of K2CO3 in DMAc has proven to be highly efficient for the coupling of a wide array of aryl bromides and iodides with acrylates in excellent yield. The coupling of 4-bromotoluene with various styrene derivatives catalyzed by Pd/6c complex also gave good results. (C) 2004 Elsevier Ltd. All rights reserved.
  • US7803800B2
    申请人:——
    公开号:US7803800B2
    公开(公告)日:2010-09-28
查看更多